Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair

Tanta University

Status: Completed

Conditions: Epigastric Hernia; Analgesia; Recto-intercostal Fascial Plane Block

Treatments: Drug: bupivacaine; Procedure: recto-intercostal fascial plane block

Study type: Interventional

Funder types: Other

Identifiers

NCT06092073

36264PR330/9/23

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy and safety bilateral recto-intercostal fascial plane block (RIFPB) in epigastric hernia.

Full description

Epigastric hernias are usually occult in obese patients, and their symptoms may mimic peptic ulcer or gallbladder disease . Hernia repair is associated with considerable postoperative pain.

The recto-intercostal fascial plane block (RIFPB) is a new novel approach that was developed by Tulgar et al., 2023 who hypothesized that when we inject a local anesthetic into the interfacial plane just inferolateral to the xiphoid, between the rectus abdominis muscle and the 6-7th costal cartilages (hence, between the cartilages and the intercostal muscles between them), blockade of the anterior branches of the nerves passing through this area can be guaranteed.

Enrollment: 40 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18-65 years.
• Both sexes.
• American Society of Anesthesiology (ASA) physical status I-II.
• Scheduled for elective epigastric hernia repair.

Exclusion criteria

• Obese patients with body mass index (BMI) >35 kg/m2.
• Patients with a large hernia containing bowel.
• Patients with local anesthetic allergy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

RIFPB group

Experimental group

Description:

Patients will receive bilateral Recto-Intercostal Fascial Plane Block (RIFPB) using 20 mL of bupivacaine 0.25% on each side.

Treatment:

Procedure: recto-intercostal fascial plane block

Drug: bupivacaine

Control group

No Intervention group

Description:

Patients will not receive the block.